Literature DB >> 16763359

Squamous cell carcinoma of the maxillary sinus: a Tata Memorial Hospital experience.

Sajid S Qureshi1, Devendra A Chaukar, Sanjay D Talole, Anil K D'Cruz.   

Abstract

BACKGROUND: The optimal treatment of maxillary sinus carcinoma remains to be defined and there is a paucity of Indian studies on the subject. AIMS: To present experience of management of squamous cell carcinoma of the maxillary sinus treated with curative intent at a single institution. SETTINGS AND
DESIGN: Retrospective study of patients with squamous cell carcinoma of the maxillary sinus who presented between 1994 to 1999.
MATERIALS AND METHODS: The records of 73 patients with squamous cell carcinoma of the maxillary sinus were analyzed. Sixty-two patients were evaluable. Forty patients (65%) were treated with surgery followed by postoperative radiotherapy, five patients (8%) were treated with radiotherapy alone, five patients (8%) were treated with surgery alone; 12 patients (19%) received chemotherapy. STATISTICAL ANALYSIS USED: Statistical analysis was done using Kaplan-Meier method.
RESULTS: The majority of patients presented with locally advanced disease (52, 84%); nodal involvement was observed in five patients (8%). The most common site of recurrence was at the primary site, which was observed in 28 patients (45%) and regional failures occurred in 10 (16%). The 3 and 5-year overall survival was 38% and 35% and the disease free survival was 29% and 26% respectively. The 5-year overall survival after surgery and postoperative radiotherapy was 42%.
CONCLUSIONS: The majority of patients present with advanced disease resulting in poor outcomes to conventional treatment modalities. Locoregional tumor progression remains a significant pattern of failure. New approaches such as neoadjuvant or concomitant chemoradiotherapy with aggressive surgery need to be considered and evaluated in prospective studies.

Entities:  

Mesh:

Year:  2006        PMID: 16763359     DOI: 10.4103/0019-509x.25772

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  8 in total

1.  A unilateral maxillary sinus tumor.

Authors:  Khalid Al-Zaabi; Marwa Al Riyami; Rashid Al-Abri
Journal:  Oman Med J       Date:  2013-05

Review 2.  Squamous cell carcinoma at maxillary sinus: clinicopathologic data in a single Brazilian institution with review of literature.

Authors:  Marcello Roter M Santos; João Paulo S Servato; Sérgio Vitorino Cardoso; Paulo Rogério de Faria; Ana Lúcia A Eisenberg; Fernando Luiz Dias; Adriano Mota Loyola
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 3.  Cancer of the paranasal sinuses.

Authors:  Sandeep Samant; Emma Kruger
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

4.  Squamous cell carcinoma in a maxillary odontogenic keratocyst: A rare entity.

Authors:  Anisha Maria; Yogesh Sharma; Amit Chhabria
Journal:  Natl J Maxillofac Surg       Date:  2011-07

Review 5.  Pathogenesis and nomenclature of odontogenic carcinomas: revisited.

Authors:  Swagatika Panda; Sujit Ranjan Sahoo; Gunjan Srivastav; Subrat Padhiary; Kanika Singh Dhull; Sonia Aggarwal
Journal:  J Oncol       Date:  2014-03-30       Impact factor: 4.375

6.  Induction chemotherapy in technically unresectable locally advanced carcinoma of maxillary sinus.

Authors:  Vanita Noronha; Vijay Maruti Patil; Amit Joshi; Muddu Vamshi Krishna; Sachin Dhumal; Shashikant Juvekar; P Pai; Pankaj Chatturvedi; Devendra Arvind Chaukar; Jai Prakash Agarwal; Sarbani Ghosh; Vedang Murthy; Anil D'cruz; Kumar Prabhash
Journal:  Chemother Res Pract       Date:  2014-05-11

7.  Metronomic palliative chemotherapy in maxillary sinus tumor.

Authors:  Vijay M Patil; Vanita Noronh; Amit Joshi; Ashay Karpe; Vikas Talreja; Arun Chandrasekharan; Sachin Dhumal; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2016 Apr-Jun

8.  Retrospective analysis of survival of patients with squamous cell carcinoma of the maxilla after primary resection and elective bilateral neck dissection: An institutional experience.

Authors:  Balakrishnan Ramalingam; Vijay Ebenezer
Journal:  Ann Maxillofac Surg       Date:  2011-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.